Literature DB >> 3718812

No evidence for the presence of poor metabolizers of sparteine in an Amerindian group: the Cunas of Panama.

T D Arias, L F Jorge, T Inaba.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3718812      PMCID： PMC1401024          DOI： 10.1111/j.1365-2125.1986.tb02841.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Migration and genetic infrastructure of the Central American Guaymi and their affinities with other tribal groups.

Authors:  R Barrantes; P E Smouse; J V Neel; H W Mohrenweiser; H Gershowitz
Journal:  Am J Phys Anthropol       Date:  1982-06       Impact factor: 2.868

2.  Comparative pharmacogenetics of sparteine and debrisoquine.

Authors:  T Inaba; A Vinks; S V Otton; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

Review 3.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

4.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

5.  The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.

Authors:  D A Evans; D Harmer; D Y Downham; E J Whibley; J R Idle; J Ritchie; R L Smith
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

6.  Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans.

Authors:  M Eichelbaum; N M Woolhouse
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  6 in total
  5 in total

1.  Uses and misuses of definitions of genetic polymorphism. A perspective from population pharmacogenetics.

Authors:  T D Arias; L F Jorge; R Barrantes
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 2.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of imipramine and desipramine.

Authors:  F R Sallee; B G Pollock
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

4.  Sparteine oxidation polymorphism in Greenlanders living in Denmark.

Authors:  K Brøsen
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

5.  Mephenytoin hydroxylation in the Cuna Amerindians of Panama.

Authors:  T Inaba; L F Jorge; T D Arias
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.